与KIF1A相关的神经疾病:治疗机会和挑战
Qing Lin1,2, Dylan Verden3, John Christodoulou1,2,4
1Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.
European journal of human genetics : EJHG
|November 27, 2025
概括
KIF1A相关的神经疾病 (KAND) 是一种罕见的神经退行性疾病. 研究强调了KANDAND.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- KIF1A相关的神经疾病 (KAND) 是一种罕见的,渐进的神经退行性疾病.
- 它源于KIF1A基因的变异,该基因对神经元中的轴突运输至关重要.
- 康德症呈现出广泛的神经症状,包括运动衰退和智力障碍.
研究的目的:
- 审查KAND的临床和分子方面.
- 为突出目前和新的治疗策略KAND.
- 强调需要针对KAND异质性的治疗方法.
主要方法:
- 关于KIF1A相关神经系统疾病的文献综述.
- 临床表型和分子机制的总结.
- 分析当前和新兴的治疗方法.
主要成果:
- 坎德是由影响轴突运输的KIF1A基因变异引起的.
- 疾病的表现非常可变,全球诊断不平等.
- 没有治愈方法;治疗重点是症状管理.
结论:
- 了解KIF1A功能和开发模型是KAND治疗的关键.
- 迫切需要针对性的治疗来解决KAND的多样性.
- 改善诊断准入对于公平的KAND护理至关重要.
更多相关视频
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
11.7K
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
4.2K
相关概念视频
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:29Microorganisms in Medicine and Therapeutics
917
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
917